Wade Walke | VP, IR |
Anne Wojcicki | Co-Founder, CEO, President & Director |
Steven Schoch | Chief Financial & Accounting Officer |
Kenneth Hillan | Head, Therapeutics |
Daniel Grosslight | Citigroup |
Good day, ladies and gentlemen, and welcome to the 23andMe's Fiscal Year 2022 Second Quarter Earnings Call. [Operator Instructions].
As a reminder, this conference call is being recorded. I would now like to introduce your host for today's conference, Wade Walke, Vice President of Investor Relations. Sir, you may begin.